Isopropyl (4-Nitrophenyl) Methylphosphonate - CAS 3735-97-5
Catalog: |
BB023261 |
Product Name: |
Isopropyl (4-Nitrophenyl) Methylphosphonate |
CAS: |
3735-97-5 |
Synonyms: |
1-[methyl(propan-2-yloxy)phosphoryl]oxy-4-nitrobenzene; 1-[methyl(propan-2-yloxy)phosphoryl]oxy-4-nitrobenzene |
IUPAC Name: | 1-[methyl(propan-2-yloxy)phosphoryl]oxy-4-nitrobenzene |
Description: | Isopropyl (4-Nitrophenyl) Methylphosphonate (CAS# 3735-97-5 ) is a useful research chemical. |
Molecular Weight: | 259.20 |
Molecular Formula: | C10H14NO5P |
Canonical SMILES: | CC(C)OP(=O)(C)OC1=CC=C(C=C1)[N+](=O)[O-] |
InChI: | InChI=1S/C10H14NO5P/c1-8(2)15-17(3,14)16-10-6-4-9(5-7-10)11(12)13/h4-8H,1-3H3 |
InChI Key: | YSHVIWJFWCEDSQ-UHFFFAOYSA-N |
Boiling Point: | 130 °C (0.5 mmHg) |
LogP: | 3.74470 |
Publication Number | Title | Priority Date |
US-2019152920-A1 | Compounds for central reactivation of organophosphorus- based compound-inhibited acetylcholinesterase and/or inactivation of organophosphorus-based acetylcholinesterase inhibitors and related compositions methods and systems for making and using them | 20171123 |
US-2013343994-A1 | Cholinesterase Inhibitors | 20120625 |
US-2017197996-A1 | Cholinesterase Inhibitors | 20120625 |
EP-2568807-A1 | Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning | 20100512 |
EP-2568807-B1 | Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning | 20100512 |
PMID | Publication Date | Title | Journal |
26705700 | 20160102 | Novel substituted phenoxyalkyl pyridinium oximes enhance survival and attenuate seizure-like behavior of rats receiving lethal levels of nerve agent surrogates | Toxicology |
26275814 | 20151002 | The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats | Toxicology |
25304213 | 20150101 | Novel nucleophiles enhance the human serum paraoxonase 1 (PON1)-mediated detoxication of organophosphates | Toxicological sciences : an official journal of the Society of Toxicology |
22247004 | 20120401 | Synthesis and in vitro and in vivo inhibition potencies of highly relevant nerve agent surrogates | Toxicological sciences : an official journal of the Society of Toxicology |
17129656 | 20070420 | Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity | Toxicology |
Complexity: | 306 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 259.06095954 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 259.06095954 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 81.4 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Phosphorus Compounds
Customers Also Viewed
-
[883-44-3]
N-(3-Hydroxypropyl)phthalimide
-
[155180-53-3]
RU-59063
-
[1009-43-4]
4-Trimethylsilylstyrene
-
[114723-27-2]
Sodium dicyclohexylsulfamate
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[74927-72-3]
(R)-(-)-N-(3,5-Dinitrobenzoyl)-alpha-phenylglycine
INDUSTRY LEADERS TRUST OUR PRODUCTS